{"id":"epinephrine-inhalation-aerosol","safety":{"commonSideEffects":[{"rate":"null","effect":"Tremors"},{"rate":"null","effect":"Nervousness"},{"rate":"null","effect":"Palpitations"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This leads to relaxation of bronchial smooth muscle, resulting in increased airflow to the lungs. Epinephrine also has a mild vasoconstrictive effect, which can help reduce nasal congestion.","oneSentence":"Epinephrine inhalation aerosol works by stimulating the beta-2 adrenergic receptors in the lungs to cause bronchodilation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:11:08.137Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Relief of acute bronchospasm in asthma and other obstructive airway diseases"}]},"trialDetails":[{"nctId":"NCT06963411","phase":"PHASE1","title":"Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Kokua Pharma Inc.","startDate":"2025-05-09","conditions":"Acute Allergic Reaction, Anaphylaxis","enrollment":16},{"nctId":"NCT01143051","phase":"PHASE1, PHASE2","title":"Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2010-01","conditions":"Asthma","enrollment":24},{"nctId":"NCT01460511","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of E004 in Children With Asthma","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2011-10","conditions":"Asthma","enrollment":70},{"nctId":"NCT01025648","phase":"PHASE1, PHASE2","title":"Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.","status":"TERMINATED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2009-12","conditions":"Asthma","enrollment":9},{"nctId":"NCT01188577","phase":"PHASE1, PHASE2","title":"Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2010-08","conditions":"Asthma, Bronchospasm, Wheezing","enrollment":23},{"nctId":"NCT01255709","phase":"PHASE2","title":"Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2010-12","conditions":"Asthma","enrollment":24},{"nctId":"NCT01737892","phase":"PHASE1, PHASE2","title":"Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults","status":"TERMINATED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2012-11","conditions":"Asthma","enrollment":21},{"nctId":"NCT01357642","phase":"PHASE3","title":"Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2011-07","conditions":"Asthma","enrollment":373}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Primatene Mist","Epinephrine Inhalation Aerosol, USP","epinephrine inhalation aerosol - HFA propelled"],"phase":"phase_3","status":"active","brandName":"epinephrine inhalation aerosol","genericName":"epinephrine inhalation aerosol","companyName":"Amphastar Pharmaceuticals, Inc.","companyId":"amphastar-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Epinephrine inhalation aerosol works by stimulating the beta-2 adrenergic receptors in the lungs to cause bronchodilation. Used for Relief of acute bronchospasm in asthma and other obstructive airway diseases.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}